← Back to Clinical Trials
Recruiting NCT05750849

NCT05750849 Impact of Serum Progesterone Levels on the Day of β-hCG Test in Artificial Cycles on the Ongoing Pregnancy Rate.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05750849
Status Recruiting
Phase
Sponsor Instituto Valenciano de Infertilidad, IVI VALENCIA
Condition Infertility, Female
Study Type OBSERVATIONAL
Enrollment 900 participants
Start Date 2023-01-25
Primary Completion 2025-12

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 50 Years
Study Type OBSERVATIONAL
Interventions
BLOOD COLLECTION FOR P4 DETERMINATION

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 900 participants in total. It began in 2023-01-25 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Prospective cohort multicentric study including infertile patients undergoing a pregnancy test on βhCG day (around ET +11), after an ET in the context of an artificial cycle and receiving LPS with vaginal natural progesterone following the clinical practice in IVI RMA (Spain).

Eligibility Criteria

Inclusion Criteria: * The subject must provide written informed consent prior to any study related procedures * Women ≤50 years old * BMI ≤ 35 kg/m2 * Adequate endometrial thickness (\>6.5mm) and pattern (Triple A structure) in the proliferative phase Exclusion Criteria: * Uterine Pathology, adnexal pathology * Systemic diseases

Contact & Investigator

Central Contact

LAURA CARACENA, MSR

✉ LAURA.CARACENA@IVIRMA.COM

📞 034 963 050 900

Frequently Asked Questions

Who can join the NCT05750849 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05750849 currently recruiting?

Yes, NCT05750849 is actively recruiting participants. Contact the research team at LAURA.CARACENA@IVIRMA.COM for enrollment information.

Where is the NCT05750849 trial being conducted?

This trial is being conducted at Valencia, Spain.

Who is sponsoring the NCT05750849 clinical trial?

NCT05750849 is sponsored by Instituto Valenciano de Infertilidad, IVI VALENCIA. The trial plans to enroll 900 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology